Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
iTeos Therapeutics Inc
About ITOS
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its EOS-984, a potentially first-in-class small molecule, focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1, a dominant transporter of extracellular adenosine, expressed on intratumoral T cells, which allows adenosine entry into the cell, disturbing T cell metabolism, expansion, effector function, and survival. It is also developing EOS-215, a potential best-in-class monoclonal antibody which antagonizes the triggering receptor expressed on myeloid cells 2.
Find out what a historical investment in iTeos Therapeutics Inc would be worth today using our ITOS stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy ITOS shares in Australia?
Buying ITOS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in iTeos Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ITOS
What is the ticker symbol of iTeos Therapeutics Inc?
The ticker symbol for iTeos Therapeutics Inc is ITOS.
How much is one share of ITOS?
One share of ITOS is valued at $10.15 as of 22 May 2026.
What is the market capitalisation of iTeos Therapeutics Inc ITOS?
As of 22 May 2026 iTeos Therapeutics Inc has a market cap of -.
What is the 52-week high for iTeos Therapeutics Inc stock?
The iTeos Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for iTeos Therapeutics Inc stock?
The iTeos Therapeutics Inc 52-week low stock price is $NaN.
Can I buy ITOS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ITOS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ITOS on Stake
- Buy ITOS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ITOS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ITOS related stocks